178 related articles for article (PubMed ID: 32271416)
1. Promoting effect of PAX5-activated lncRNA UASR1 on growth of colorectal cancer by regulating the mTOR pathway.
Wang W; Wang Z; Wang H; Li X; Wang HT
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2986-2993. PubMed ID: 32271416
[TBL] [Abstract][Full Text] [Related]
2. STAT1-induced upregulation of lncRNA LINP1 promotes cell proliferation and inhibits apoptosis via AMPK signaling pathway in papillary thyroid cancer.
Li HP; Yang TZ; Wei L; Ge YF; Meng QS
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8911-8917. PubMed ID: 32964981
[TBL] [Abstract][Full Text] [Related]
3. Silencing of linc00337 inhibits proliferation, cell cycle progression, migration, and invasion of colorectal cancer cells through the MEK/ERK pathway.
Wang ZG; Yang YG; Fu GS; Lu DH; Tian SY; Wei W
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5353-5359. PubMed ID: 32495869
[TBL] [Abstract][Full Text] [Related]
4. Low expression of lncRNA TUBA4B promotes proliferation and inhibits apoptosis of colorectal cancer cells via regulating P15 and P16 expressions.
Zhou YG; Sun F; Zhou YF
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3023-3029. PubMed ID: 32271419
[TBL] [Abstract][Full Text] [Related]
5. LINC01198 promotes colorectal cancer cell proliferation and inhibits apoptosis via Notch signaling pathway.
Chen S; Yuan H; Chen BC; Wan ZA; Tu SL; Hu XY
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8439-8446. PubMed ID: 32894550
[TBL] [Abstract][Full Text] [Related]
6. [LncRNA SNHG11 promotes malignant progression of colorectal cancer cells through the PI3K/Akt/mTOR signaling pathway].
Tao SN; Liu XC; Wang YY; Yang H
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(10):758-765. PubMed ID: 38462356
[No Abstract] [Full Text] [Related]
7. LncRNA FBXL19-AS1 promotes proliferation and metastasis via regulating epithelial-mesenchymal transition in non-small cell lung cancer.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4800-4806. PubMed ID: 31210311
[TBL] [Abstract][Full Text] [Related]
8. LINC01605 regulates proliferation, migration and invasion of colorectal cancer cells via targeting miR-3960/SOX11.
Hu SS; Fu L; Han SY; Li XL; Zhang LD
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1322-1329. PubMed ID: 33629302
[TBL] [Abstract][Full Text] [Related]
9. lncRNA GAS5 inhibits malignant progression by regulating macroautophagy and forms a negative feedback regulatory loop with the miR‑34a/mTOR/SIRT1 pathway in colorectal cancer.
Zhang HG; Wang FJ; Wang Y; Zhao ZX; Qiao PF
Oncol Rep; 2021 Jan; 45(1):202-216. PubMed ID: 33416133
[TBL] [Abstract][Full Text] [Related]
10. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
11. LINC01535 promotes proliferation and inhibits apoptosis in esophageal squamous cell cancer by activating the JAK/STAT3 pathway.
Fang Y; Zhang S; Yin J; Shen YX; Wang H; Chen XS; Tang H
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3694-3700. PubMed ID: 32329845
[TBL] [Abstract][Full Text] [Related]
12. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
Li H; Jiang X; Niu X
Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NR2F1-AS1 promotes proliferation and metastasis of ESCC cells via regulating EMT.
Ren P; Zhang H; Chang L; Hong XD; Xing L
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3686-3693. PubMed ID: 32329844
[TBL] [Abstract][Full Text] [Related]
16. SP1-regulated LINC01638 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
Guo L; Fang L; Liu Y
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8913-8920. PubMed ID: 31696478
[TBL] [Abstract][Full Text] [Related]
17. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
18. lncRNA UASR1 sponges miR-107 in colorectal cancer to upregulate oncogenic CDK8 and promote cell proliferation.
Zhang Q; Chen Z
Oncol Lett; 2020 Dec; 20(6):305. PubMed ID: 33093914
[TBL] [Abstract][Full Text] [Related]
19. LINC00355 inhibits apoptosis and promotes proliferation of gastric cancer cells by regulating Wnt/β-catenin signaling pathway.
Luan PB; Sun XM; Yao J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8377-8383. PubMed ID: 32894544
[TBL] [Abstract][Full Text] [Related]
20. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
